TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,040,767 | +13.7% | 67,276 | +17.3% | 0.08% | +17.9% |
| Q2 2023 | $915,038 | +26.9% | 57,370 | +31.1% | 0.07% | +19.6% |
| Q1 2023 | $721,005 | +35.4% | 43,750 | +28.1% | 0.06% | +12.0% |
| Q4 2022 | $532,605 | +101.7% | 34,141 | +85.0% | 0.05% | +100.0% |
| Q1 2022 | $264,000 | +26.9% | 18,453 | +21.1% | 0.02% | +47.1% |
| Q4 2021 | $208,000 | +7.2% | 15,237 | +28.7% | 0.02% | 0.0% |
| Q3 2021 | $194,000 | -36.2% | 11,840 | -28.9% | 0.02% | -48.5% |
| Q1 2021 | $304,000 | +56.7% | 16,656 | +53.0% | 0.03% | +22.2% |
| Q3 2020 | $194,000 | +2.1% | 10,887 | +4.5% | 0.03% | -6.9% |
| Q2 2020 | $190,000 | – | 10,418 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |